News

Epicel is the first xenotransplantation-classified product to be approved in the US because of its inclusion of animal cells. It is a product that can provide permanent skin

The candidate, CPG 52364, is a small molecule toll-like receptor (TLR) antagonist designed to specifically inhibit TLRs 7, 8 and 9 and inhibit disease development in systemic lupus

Under the terms of the agreement, River’s Edge acknowledges the validity and enforceability of the Nicomide patent. River’s Edge has agreed to make a lump-sum settlement payment to

The approvable letter relates to the use of Mucinex with Codeine in the prescription treatment of cough associated with the common cold, inhaled irritants and stable chronic bronchitis.

The preliminary results of the Phase I/II trial demonstrated that CTCE-9908 is well tolerated with no dose limiting toxicity observed up to the maximum dose of 5mg/kg/day that

The company expects that the Phase II clinical trial will provide a robust statistical assessment, confirm the proposed dosing regimen and support the initiation of a Phase III

Under the termination agreement, Novavax will complete the manufacture of remaining orders for the product and plans to close its Philadelphia manufacturing facility over the next few months.

The study is an open-label, multi-center, six-week trial conducted in hospitalized patients with treatment resistant schizophrenia, in which BL-1020 showed statistically significant efficacy with minimal side effects. The

ViraNative filed for bankruptcy in September and Swedish Orphan International acquired the bankruptcy estate. Through this takeover Swedish Orphan International has acquired the worldwide rights for the drug